Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome

Clinical trial NCT00001596 · COMPLETED

Trial details

NCT number: NCT00001596
Sponsor: William Gahl, M.D.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Albinism Inborn Errors of Metabolism Oculocutaneous Albinism Platelet Storage Pool Deficiency Pulmonary Fibrosis

Start date: 2005-09-01
Primary completion: 2009-09-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.